Influenza vaccine does not only work against influenza. Also, it reduces the risk of dying, having blood clots or bleeding in the brain, among the elderly in the critical care unit if they have been vaccinated.
This is despite the fact that they are typically older, have more chronic diseases and take more medicine then those who have not been vaccinated.
Common Food Preservative May Influence How Well Flu Vaccines Work
Common food preservative Tert-butylhydroquinone, or tBHQ found in food products such as cooking oils, processed foods and frozen meats may influence the effectiveness of flu vaccines.
Advertisement
‘Vaccination for influenza reduces the mortality risk among older adults who require critical care.’
Read More..
Tweet it Now
Read More..
The study covers almost 90,000 surviving intensive care patients above the age of 65 during an eleven year period in Denmark. Only a few of them were admitted directly due to influenza. However, regardless of the cause of the admission, for those who were vaccinated the risk of suffering a stroke - which is the collective name for bleeding and blood clots in the brain - was 16 per cent lower. This group also has an eight per cent lower risk of dying during the first year following their hospitalisation.
"Every year, 30,000 people are admitted to the intensive care units in Danish hospitals and we know that the first year is critical. Approximately three out of four survive the hospitalisation and are discharged from hospital. But even among the patients who are discharged, almost one in five die within the first year while many others suffer complications. Our study shows that there are fewer deaths and serious complications among the patients who have been vaccinated against influenza. So this supports the current recommendation that elderly people should be vaccinated," says Christian Fynbo Christiansen, clinical associate professor at Aarhus University Hospital and consultant at Aarhus University Hospital, Denmark.
![Seasonal Flu Vaccine’s Efficiency can be Improved]( "Seasonal Flu Vaccine’s Efficiency can be Improved")
An efficient way to boost the efficacy of vaccines against influenza type B might be hiding in plain sight. By exploiting the flu vaccine to elicit more of a NA-related response like the one found in these studies, they could go further in developing a universal vaccine.
Today, less than forty per cent of elderly Europeans say yes to the vaccination.
"We can't say with one hundred per cent certainty that the risk of a stroke and dying is lower solely because of the vaccine. But we can see that the elderly people who have been vaccinated do better in the event of critical illness. This suggests that it would be good if more elderly people received the vaccine. Not least because the vaccine is both safe and inexpensive," says Christian Fynbo Christiansen.
This is the first time that researchers have looked into the effect of the vaccine specifically on elderly critically ill patients. Other researchers have previously shown that the influenza vaccine lessens the risk of bacterial infections and heart attacks. However, the study shows that this is not the case for the elderly intensive care patients.
"Surprisingly, the vaccine didn't reduce the number of pneumonia cases in our study. We had otherwise expect that it would, as some previous studies have shown that the vaccine has this effect on younger and healthy individuals. Neither was there any clear difference in the number of blood clots in the heart. This raises new research questions about what effect of the vaccine on the immune system and whether there were other differences between the patients," says Christian Fynbo Christiansen.
The research results - more information:
The study is a register-based cohort study that covers 89,818 patients who have survived hospitalisation in intensive care departments in Denmark during the period 2005-2015. Patients have been identified in the Danish Intensive Database along with associated information from other health registers.
Source: Eurekalert
Seasonal Flu Vaccine’s Efficiency can be Improved
An efficient way to boost the efficacy of vaccines against influenza type B might be hiding in plain sight. By exploiting the flu vaccine to elicit more of a NA-related response like the one found in these studies, they could go further in developing a universal vaccine.
Advertisement
Today, less than forty per cent of elderly Europeans say yes to the vaccination.
"We can't say with one hundred per cent certainty that the risk of a stroke and dying is lower solely because of the vaccine. But we can see that the elderly people who have been vaccinated do better in the event of critical illness. This suggests that it would be good if more elderly people received the vaccine. Not least because the vaccine is both safe and inexpensive," says Christian Fynbo Christiansen.
This is the first time that researchers have looked into the effect of the vaccine specifically on elderly critically ill patients. Other researchers have previously shown that the influenza vaccine lessens the risk of bacterial infections and heart attacks. However, the study shows that this is not the case for the elderly intensive care patients.
"Surprisingly, the vaccine didn't reduce the number of pneumonia cases in our study. We had otherwise expect that it would, as some previous studies have shown that the vaccine has this effect on younger and healthy individuals. Neither was there any clear difference in the number of blood clots in the heart. This raises new research questions about what effect of the vaccine on the immune system and whether there were other differences between the patients," says Christian Fynbo Christiansen.
The research results - more information:
The study is a register-based cohort study that covers 89,818 patients who have survived hospitalisation in intensive care departments in Denmark during the period 2005-2015. Patients have been identified in the Danish Intensive Database along with associated information from other health registers.
Source: Eurekalert
Candidate for Universal Flu Vaccine Protects Against Multiple Strains: Study
A universal flu vaccine that protects people against most influenza strains is one step closer to reality, say researchers.
Advertisement
 Flu Vaccine can Now be Given in a PillFlu vaccine that can be administered as a pill has been developed by British scientists. This is the world's first non-biologic influenza vaccine and could herald a revolution in vaccine delivery. | Advertisement
|
Advertisement
Recommended Reading
Latest Respiratory Disease News
According to the Centers for Disease Control and Prevention (CDC), there was a notable increase in infections caused by human metapneumovirus (HMPV), an emerging threat.
The new cell culture technology platform allows researchers to react to the next pandemic with much more speed and precision.
A new artificial intelligence-enabled chest imaging technology performs a deep characterization of the pulmonary vasculature to detect pulmonary (arterial) hypertension.
The global climate crisis is stimulating heat waves to become more frequent causing distress to people with asthma, say experts.
A new study reveals vitamin D3 supplements have encouraging effects for asthma patients. Vitamin D has a positive effect on immune response.